Cargando…
Sequential control of myeloid cell proliferation and differentiation by cytokine receptor-based chimeric antigen receptors
As chimeric antigen receptor (CAR)-T cell therapy has been recently applied in clinics, controlling the fate of blood cells is increasingly important for curing blood disorders. In this study, we aim to construct proliferation-inducing and differentiation-inducing CARs (piCAR and diCAR) with two dif...
Autores principales: | Nakajima, Kyoko, Shen, Zhongchuzi, Miura, Masashi, Nakabayashi, Hideto, Kawahara, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794043/ https://www.ncbi.nlm.nih.gov/pubmed/36574389 http://dx.doi.org/10.1371/journal.pone.0279409 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia
por: Koedam, Jan, et al.
Publicado: (2022) -
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
por: Fan, Mingxue, et al.
Publicado: (2017) -
Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
por: Marvin-Peek, Jennifer, et al.
Publicado: (2022) -
Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
por: Schorr, Christopher, et al.
Publicado: (2022) -
Engineering Chimeric Antigen Receptors
por: Kulemzin, S. V., et al.
Publicado: (2017)